Penn Medicine Provider
Medical Oncology
David W. Dougherty, MD, MBA
5.0
(68)
Accepting new patients
Sees patients age 18 and up
Abramson Cancer Center Perelman 2nd Floor West
Make an appointmentCall 215-615-5858

About me

  • Deputy Director, Clinical Services, Abramson Cancer Center
  • Associate Professor of Clinical Medicine (Hematology-Oncology)

Education and training

  • Medical School: Jefferson Medical College
  • Residency: Penn State Milton S. Hershey Medical Center
  • Fellowship: University of Rochester Medical Center

What my patients think about me

Average Rating
5.0

68 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

May 2025
5.0
5.0
would recommend to anyone
April 2025
5.0
5.0
good visit.
April 2025
5.0
5.0
knowledgeable, kind, compassionate, caring
March 2025
5.0
5.0
excellent patient rapport. clear explanations of all findings. takes time with the patient to answer all questions. kind.

Insurance accepted

My Locations

Learn about location

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
Dr. Dougherty is a Penn Medicine physician.

Qualifications and experience

My research

17., Marmarelis ME, Scholes DG, McWilliams TL, Hwang WT, Kosteva J, Costello MR, Sun L, Singh AP, Lau-Min KS, Doucette A, Gabriel PE, Martella AO, Roy MA, Thompson JC, Cohen RB, Dougherty DW, Shulman LN, Langer CJ, Bekelman JE, Carpenter EL, Aggarwal C Electronic Medical Record-Based Nudge Intervention to Increase Comprehensive Molecular Genotyping in Patients with Metastatic Non-Small Cell Lung Cancer: Results from a Prospective Clinical Trial. , JCO Oncol Pract: 2024

Wainwright, JV, Aggarwal C, Beucker S, Dougherty DW, et al Penn TRACE. University of Pennsylvania Telehealth Research Center of Excellence. , J Natl Cancer Inst Monogr: 2024,62-69

16., Siegel RD, LeFebvre KB, Temin S, Evers A, Barbarotta L, Bowman R, Chan A, Dougherty DW, et al Antineoplastic Therapy Administration Safety Standards for Adult and Pediatric Oncology: ASCO-ONS Standards. , Oncol Nurs Forum , 51(4): 2024,297-320

15., Siegel RD, LeFebvre KB, Temin S, Evers A, Barbarotta, L, Bowman R, Chan A, Dougherty DW, et al. Antineoplastic Therapy Administration Safety Standards for Adult and Pediatric Oncology : ASCO-ONS Standards. , JCO Oncology Practice : 2024,1-17

Sedhom R, Tomita-Barber J, Manz CR, Parikh RB, Gupta A, Hussaini Q, Dougherty D Creating a culture for change: Lessons from behavioral economics and complexity science to increase serious illness conversations for patients with cancer , Curr Probl Cancer: 2023

21., Grossi R, Tadessee E, Mabunda L, Austin T, Angers K, Tutuska K, Daigle M, Eggly S, Dougherty D, Hamel LM Recruiting Black and white patients to a behavioral oncology clinical trial: lessons from the DISCO Trial , ASCO Quality Care Symposium, Boston, MA: 2023

Roberts DA, Faig J, Bodio-Downey K, Shpilsky J, Leahy K, Wischhusen J, Giordano S, Acharya U, Drews R, Dougherty D, Lathan C, Rangachari D Training Hematologists/Oncologists for the Academic-Community Hybrid: Creating a Fellowship Framework for the Future , JCO Oncol Pract, 19(6): 2023,e927-e934

19., Sedhom R, Goldman NA, Celaya K, Mastro KA, Ortiz P, Dougherty DW Feasibility of Integrating Geriatric Oncology and Palliative Care Assessment into the Routine Care of Older Adults in a Community Setting , ASCO 2023 Annual Meeting, Chicago, IL: 2023

Sedhom R - full author list pending Goals, Values, and Priorities of Older Adults with Cancer in a Community Practice. , Annual Conference of the International Society of Geriatric Oncology, Valencia, Spain: 2023

Hamel LM, Robinson LM, Chamblee M, Roy D, Dougherty DW, Sood B Designing and implementing an evidence-based and longitudinal implicit bias training curriculum for school of medicine members and health care providers , ASCO 2022 Quality Care Symposium, Chicago, IL / J Clin Oncol, 40: 2022